Full video transcriptClick to expand
Auto-generated transcript of @grayson.smith12's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00This is two months of taking testosterone.
- 0:02A while ago, I went to a medical lab center
- 0:04that specializes in hormone treatment therapy.
- 0:06I ran my labs and saw that my testosterone levels
- 0:09were really, really, really low.
- 0:10I was struggling a lot with extreme fatigue, brain fog,
- 0:13just feeling like it was always like getting sick,
- 0:16like just sickly in general.
- 0:18My nurse after getting the labs drawn
- 0:19suggested I go on testosterone to replace
- 0:22my super, super low levels.
- 0:24After two months of being on it,
- 0:25I wanted to give you guys an update
- 0:26because I'm feeling so much better.
- 0:28Honestly, I'm not sure if it's a placebo thing or what,
- 0:31but I don't have that mid-day crash anymore.
- 0:34Like around two, three, I would just feel so sluggish
- 0:37like at work.
- 0:38I'm honestly feeling so much better.
- 0:39I haven't experienced any of the negative side effects
- 0:41that they say comes with taking testosterone,
- 0:44like increased acne or like growing excess body hair
- 0:47anywhere.
- 0:48I haven't had any of those symptoms, which is great.
- 0:50I just had my checkup yesterday and I said
- 0:52that my levels had quadrupled.
- 0:54So it's definitely working.
- 0:56If you're interested in something like that,
- 0:57see if there's a hormone therapy treatment center near you.
- 1:01I definitely recommend it.
- 1:02Just getting your levels tested anyway
- 1:04was super insightful to me.
- 1:05So if you have any questions, comment down below
- 1:07and I will answer them.
Two months on testosterone: what the science says about early TRT results
Quick answer
The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism. At two months, she reports symptomatic improvement and a fourfold increase in testosterone levels, though the absolute values and whether levels are now within physiologic range for women are not disclosed. Two months is insufficient to assess the full side effect profile or long-term efficacy of testosterone therapy in female patients.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Two months on testosterone: what the science says about early TRT results, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Two months on testosterone: what the science says about early TRT results should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Two months on testosterone: what the science says about early TRT results" from Grayson Smith. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism.
The reason this review is not generic is the source wording and the canonical claim label "trt 2 months on testosterone update hormonetherapy testosterone." In this clip, the useful excerpt is: "This is two months of taking testosterone." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism. At two months, she reports symptomatic improvement and a fourfold increase in testosterone levels, though the absolute values and whether levels are now within physiologic range for women are not disclosed. Two months is insufficient to assess the full side effect profile or long-term efficacy of testosterone therapy in female patients.
- Female testosterone deficiency is real, but reference ranges vary by lab and age, and most standard panels miss free testosterone and SHBG, the values that reflect how much is actually bioavailable.
- A 2019 systematic review (Davis et al., Lancet Diabetes and Endocrinology) found evidence for testosterone therapy in women is strongest for sexual function, and much weaker for fatigue and cognitive symptoms specifically.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Female testosterone deficiency is real, but reference ranges vary by lab and age, and most standard panels miss free testosterone and SHBG, the values that reflect how much is actually bioavailable.
- A 2019 systematic review (Davis et al., Lancet Diabetes and Endocrinology) found evidence for testosterone therapy in women is strongest for sexual function, and much weaker for fatigue and cognitive symptoms specifically.
- Two months is not enough to assess the full side effect profile. Islam et al. (2021, Clinical Endocrinology) found androgenic effects in women typically emerge at 3-6 months of therapy.
- Placebo responses in testosterone trials can account for 30-40% symptom improvement (Rao et al., 2014, JAMA), which is why the creator's own uncertainty about placebo is actually the most scientifically honest part of her video.
- Before attributing fatigue and brain fog to low testosterone, thyroid dysfunction, iron deficiency anemia, sleep apnea, and depression should all be ruled out, as these conditions produce identical symptoms.
- The Endocrine Society's 2014 clinical practice guidelines recommend against treating women with testosterone unless both low levels are documented and symptoms have not responded to other interventions.
- A fourfold increase in testosterone tells you very little without knowing the starting value and the landing value. Getting into normal physiologic range is the goal. Exceeding it is a clinical problem, not a success metric.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @grayson.smith12 actually say?
Grayson described going to a hormone clinic, getting labs that showed "really, really, really low" testosterone, and starting testosterone replacement therapy on her nurse's recommendation. After two months, she says she no longer has the "mid-day crash" and feels better overall. She also reports zero side effects, and claims her levels "quadrupled" at her two-month checkup.
She's careful to hedge, saying "I'm not sure if it's a placebo thing or what." That's actually a more honest disclosure than most TRT content on TikTok. She stops short of telling viewers to go on testosterone, and instead suggests getting levels tested. Her recommendation is mostly reasonable, but there are some gaps in the clinical picture she's painting that are worth unpacking.
Does the science back this up?
Partly, yes. Female hypogonadism is real, underdiagnosed, and genuinely associated with fatigue, brain fog, and low energy. The symptom improvement she describes is consistent with what the literature shows for women with documented low testosterone.
A 2019 systematic review by Davis et al. in The Lancet Diabetes and Endocrinology found that testosterone therapy in women improved sexual function and some quality-of-life markers, but the evidence for fatigue and cognitive symptoms specifically is still limited and context-dependent. The placebo response in hormone studies is also well-documented and can account for significant symptom relief in the short term, which Grayson herself acknowledges. A 2014 trial by Rao et al. in JAMA found that placebo arms in testosterone studies sometimes show 30-40% symptom improvement. Two months is also not enough time to draw firm conclusions about long-term efficacy or safety in most endocrine protocols.
What did they get wrong (or right)?
She got the basic premise right: if your testosterone is genuinely low and symptomatic, replacement therapy can help. Credit where it's due.
What she got wrong, or at least incomplete, is the side effect picture. She says she "hasn't experienced any of the negative side effects," but two months is a very short window. Acne and hair growth can emerge later as levels stabilize or if dosing shifts. More importantly, she doesn't mention other potential effects that matter in female patients, including changes to menstrual cycles, clitoral sensitivity, voice changes, and lipid profile shifts. A 2021 review by Islam et al. in Clinical Endocrinology noted that androgenic side effects in women often appear after 3-6 months, not in the first eight weeks. Her clean bill of health at two months is not the full story.
The claim that her levels "quadrupled" also needs context. Quadrupling from severely deficient to normal is the goal. Quadrupling into supraphysiologic range would be a problem. She doesn't say where her levels landed, and that distinction matters clinically.
What should you actually know?
Low testosterone in women is a real and underrecognized condition, but diagnosis is genuinely complicated. Reference ranges for female testosterone vary significantly by lab and by age, and many standard lab panels don't capture free testosterone or SHBG, which affect how much testosterone is actually bioavailable. Getting a number without the full panel can be misleading.
If you're experiencing fatigue, brain fog, and low energy, testosterone is one possible explanation, but it is far from the only one. Thyroid dysfunction, iron deficiency, sleep apnea, and mood disorders can all produce identical symptoms and should be ruled out before starting hormone therapy. The Endocrine Society's 2014 clinical practice guidelines explicitly recommend against treating women with testosterone unless there is both a documented low level and clear symptoms that haven't responded to other interventions.
Grayson's advice to get your levels tested is reasonable. Her implicit suggestion that a hormone clinic is the right first stop is worth questioning. A primary care physician or endocrinologist with full labs is a better starting point for most people.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Grayson Smith · TikTok creator
143.3K views on this video
2 months on testosterone update #HormoneTherapy #Testosterone #FemaleTestosterone #TestosteroneReplacement #TestosteroneTherapy #Hormones.
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about female testosterone deficiency?
Female testosterone deficiency is real, but reference ranges vary by lab and age, and most standard panels miss free testosterone and SHBG, the values that reflect how much is actually bioavailable.
What does the video say about a 2019 systematic review (davis et al., lancet diabetes?
A 2019 systematic review (Davis et al., Lancet Diabetes and Endocrinology) found evidence for testosterone therapy in women is strongest for sexual function, and much weaker for fatigue and cognitive symptoms specifically.
What does the video say about two months?
Two months is not enough to assess the full side effect profile. Islam et al. (2021, Clinical Endocrinology) found androgenic effects in women typically emerge at 3-6 months of therapy.
What does the video say about placebo responses in testosterone trials can account for 30-40% symptom?
Placebo responses in testosterone trials can account for 30-40% symptom improvement (Rao et al., 2014, JAMA), which is why the creator's own uncertainty about placebo is actually the most scientifically honest part of her video.
What does the video say about before attributing fatigue?
Before attributing fatigue and brain fog to low testosterone, thyroid dysfunction, iron deficiency anemia, sleep apnea, and depression should all be ruled out, as these conditions produce identical symptoms.
What does the video say about the endocrine society's 2014 clinical practice guidelines recommend against treating?
The Endocrine Society's 2014 clinical practice guidelines recommend against treating women with testosterone unless both low levels are documented and symptoms have not responded to other interventions.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Grayson Smith, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.